BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5134838)

  • 1. Failure of soluble fibrin to influence the erythrocyte sedimentation rate.
    Godal HC; Kierulf P
    Scand J Haematol; 1971; 8(5):415-6. PubMed ID: 5134838
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contents of soluble fibrin monomer complexes and fibrinogen in the plasma and erythrocyte sedimentation rate].
    Kleniewski J
    Pol Tyg Lek; 1971 Apr; 26(17):627-9. PubMed ID: 5092297
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel characteristics of soluble fibrin: hypercoagulability and acceleration of blood sedimentation rate mediated by its generation of erythrocyte-linked fibers.
    Galanakis DK; Protopopova A; Li K; Yu Y; Ahmed T; Senzel L; Heslin R; Gouda M; Koo J; Weisel J; Manco-Johnson M; Rafailovich M
    Cell Tissue Res; 2022 Mar; 387(3):479-491. PubMed ID: 35275281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin treated plasma employed as a standard for determination of soluble fibrin.
    Halvorsen S; Skjønsberg OH; Godal HC
    Thromb Res; 1993 Nov; 72(4):305-13. PubMed ID: 8303670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stimulatory effect of soluble fibrin on plasminogen activation by tissue plasminogen activator as studied by the Coa-set Fibrin Monomer test.
    Halvorsen S; Skjønsberg OH; Godal HC
    Thromb Res; 1991 Feb; 61(4):453-61. PubMed ID: 1905851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased whole blood viscosity during coronary artery bypass surgery. Studies to evaluate the effects of soluble fibrin and poloxamer 188.
    Hunter RL; Papadea C; Gallagher CJ; Finlayson DC; Check IJ
    Thromb Haemost; 1990 Feb; 63(1):6-12. PubMed ID: 2339361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte sedimentation and soluble fibrin monomer complexes.
    Lipiński B; Worowski K; Myśliwiec M; Farbiszewski R
    Thromb Diath Haemorrh; 1969 Apr; 21(2):196-202. PubMed ID: 5769048
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on soluble fibrin in plasma. 3. N-terminal analysis of a modified fraction I (Cohn) from plasmin- and thrombin-incubated plasma.
    Kierulf P
    Scand J Clin Lab Invest; 1973 Jan; 31(1):43-9. PubMed ID: 4687776
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanism of blood sedimentation. XVI. Inhibition of the fibrinogen sedimentation effect by fibrinogen substrates].
    Ancker E; Wagner HJ; Hörmann H; Ruhenstroth-Bauer G
    Blut; 1971 Sep; 23(3):155-62. PubMed ID: 5113515
    [No Abstract]   [Full Text] [Related]  

  • 10. A simple rapid method for isolating soluble fibrin complexes from fibrinogen by treatment with thrombin and t-AMCHA.
    Hayashi S; Yamada K
    Thromb Haemost; 1980 Feb; 42(5):1388-97. PubMed ID: 6154323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of the anti-factor VIII effect of thrombin in plasma by the plasminolytic derivatives of fibrinogen and fibrin.
    Chandra S; Triantaphyllopoulos DC
    Thromb Diath Haemorrh; 1973 Nov; 30(2):235-47. PubMed ID: 4272616
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanism of erythrocyte sedimentation. XV. Characterization of various bovine fibrinogen fractions using erythrocyte sedimentation rate, thrombin time and immunodiffusion].
    Ancker E; Wuppermann T; Hörmann H; Ruhenstroth-Bauer G
    Blut; 1971 Jun; 22(6):320-9. PubMed ID: 4997678
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective immobilization of alpha-thrombin by surface-bound fibrin.
    Wilner GD; Danitz MP; Mudd MS; Hsieh KH; Fenton JW
    J Lab Clin Med; 1981 Mar; 97(3):403-11. PubMed ID: 7462772
    [No Abstract]   [Full Text] [Related]  

  • 14. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conversion of fibrinogen to fibrin. XIII. Dissolution of fibrin and inhibition of clotting by various neutral salts.
    SHULMAN S; KATZ S; FERRY JD
    J Gen Physiol; 1953 Jul; 36(6):759-66. PubMed ID: 13069679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the thrombin clotting time. II. The influence of fibrin degradation products.
    Arnesen H
    Scand J Haematol; 1973; 10(4):291-7. PubMed ID: 4764611
    [No Abstract]   [Full Text] [Related]  

  • 17. Soluble, cross-linked fibrin(ogen) hybrid oligomers do not stimulate t-PA conversion of plasminogen.
    Grøn B; Bennick A; Filion-Myklebust C; Matsueda GR; Nieuwenhuizen W; Brosstad F
    Thromb Res; 1992 May; 66(2-3):231-8. PubMed ID: 1412194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin activity of fibrin thrombi and soluble plasmic derivatives.
    Francis CW; Markham RE; Barlow GH; Florack TM; Dobrzynski DM; Marder VJ
    J Lab Clin Med; 1983 Aug; 102(2):220-30. PubMed ID: 6223106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of intrinsic prothrombin activation by fibrinogen and fibrin I.
    Okwusidi JI; Anvari N; Ofosu FA
    J Lab Clin Med; 1993 Jan; 121(1):64-70. PubMed ID: 8426082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electron microscopic study of the depolymerization process on unstabilized fibrin as affected by urea or monochloracetic acid].
    Ul'ianov AM; Zhitnikova ES
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (8):59-63. PubMed ID: 6226322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.